I could not be any happier!!!The vast majority of SH will be...

I could not be any happier!!!

The vast majority of SH will be thrilled with this.

All the signs pointed to it, and all of MT's signals headed in this direction.

If we asked any of these questions:

Who is ready for the job role?

• fully-briefed; immediately available; extensively-connected; greatly admired;

• has proven biotech business acumen; is skilled in commercial deals;

• has the thorough confidence and trust of the SH;

• is open, transparent and engaging to SH and stakeholders;

• has intimate knowledge of the product;

• determined the MPL value proposition;

• experienced in FDA processes; has a successful trialling record;

• knows the industry players; goes on the front foot and pounds the pavements;

• is transitioning PAA to be a leading developer of neurodegenerative medicines;

• is perceptive in all of the nuances of PAA’s current position and future pathways;

• and is thoroughly experienced and completely across all aspects of the current CEO job role?

There’s only one answer = Dr Michael Thurn.

Congrats to all who believed and remained patient.

Onwards,

Greatly relieved,

Ice